Open Access Green as soon as Postprint is submitted to ZB.
The combination of crenolanib and azacitidine effectively targets leukemia-initiating cells in FLT3-ITD+ AML to overcome protection by the bone marrow niche.
Oncol. Res. Treat. 38, 214 (2015)
Edit extra informations Login
Publication type Article: Journal article
Document type Meeting abstract
Institute(s) Research Unit Gene Vector (AGV)